BG Medicine, Inc. (BGMD)

OTCMKTS: BGMD · Delayed Price · USD
0.00 0.00 (0.00%)
Jan 25, 2022 11:54 PM EST - Market closed
Market Capn/a
Revenue (ttm)1.57M
Net Income (ttm)-6.96M
Shares Out11.37M
EPS (ttm)-0.72
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Beta0.48
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BGMD

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and is...

IndustryLife Sciences Tools & Services
IPO DateFeb 4, 2011
CEOPaul Sohmer
Employees5
Stock ExchangeOTCMKTS
Ticker SymbolBGMD
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.